Prescription Drugs: Issues in Treatment, Supervision and Case Management
|
|
- Deborah Dixon
- 6 years ago
- Views:
Transcription
1 Prescription Drugs: Issues in Treatment, Supervision and Case Management National Association of Drug Court Professionals Washington, DC July 16, 2013
2 Agenda Overview of prescription drug diversion and abuse PDMP processes and functions PDMPs and law enforcement PDMPs and case management
3 Prescription Drug Diversion and Abuse Key Points
4 Motor vehicle traffic, poisoning, and drug poisoning (overdose) death rates United States, Motor Vehicle Traffic Poisoning Drug Poisoning (Overdose) Deaths per 100,000 population Year Source: NCHS Data Brief, December, 2011, Updated with 2009 and 2010 mortality data
5 Drug Overdose Deaths by Major Drug Type, U.S., ,000 Opioids Heroin Cocaine Benzodiazepines 16,000 14,000 Number of Deaths 12,000 10,000 8,000 6,000 4,000 2, Year Source: CDC, National Center for Health Statistics, National Vital Statistics System. Updated with 2010 mortality data
6 Rates of opioid overdose deaths, sales and treatment admissions, U.S., Opioid Sales KG/10,000 Opioid Deaths/100,000 Opioid Treatment Admissions/10, Rate Year Source: National Vital Statistics System, DEA s Automation of Reports and Consolidated Orders System, SAMHSA s TEDS
7 Drug overdose death rate 2008 and opioid pain reliever sales rate 2010 Kg of opioid pain relievers used per 10,000 Age-adjusted rate per 100,000 Source: National Vital Statistics System, 2008; Automated Reports Consolidated Orders System (2010)
8 Past year initiates of specific illicit drugs among persons aged 12 or older: 2010 Source: SAMHSA
9 Past month nonmedical use of types of psychotherapeutic drugs among persons aged 12 or older: Source: SAMHSA
10 Rates of ED visits per 100,000 population involving nonmedical use of pharmaceuticals, by age: 2011 Source: SAMHSA
11 Number of Forensic Cases Source: DEA, 2013
12 Opioid Epidemic Iatrogenic Opioid overdoses and deaths rise to epidemic proportions first decade of 2000s Different than any other drug epidemic: Manufactured by pharmaceutical manufacturers Distributed throughout our health care system Prescribed by physicians and other licensed professionals Dispensed by pharmacies Challenge: Need to balance enabling medical use with preventing misuse and abuse
13 What do Prescription Drug Monitoring Programs do?
14 Prescription Drug Monitoring Program GOALS Education & Information Public Health Initiatives Early Intervention & Prevention Investigation & Enforcement Source: Alliance of States with Prescription Monitoring Programs
15 PDMP System Overview Dispensers Data Submitted Pharmacists Reports Sent State PDMP Reports Sent Prescribers Reports Sent Law Enforcement & Professional Licensing Agencies *Groups other than those listed may also receive reports
16 Prescription Information PDMPs Collect Patient identification: Name & Address DOB & Gender Prescriber Information Dispensing Pharmacy Information Drug Information, e.g. NDC # = name, type, strength, manufacturer Quantity & date dispensed Source of payment (some states)
17 Data Collected from Pharmacies PDMPs Collect Dispensed Controlled Substances (CS) Rx: 30 collect Schedules II - V 18 collect Schedules II IV 1 collects Schedule II & III 1 collects Schedules II only Some Collect Non-Controlled Prescription Substances 8 collect tramadol (Ultram ) 1 each Butorphanol, butalbitol w/ acetamenophen Electronic Data Collection - Batch Reporting Reporting Frequency varies POS, 24 hours, 7 to 30 days
18 Data is Provided to: PDMP Data Doctors and other prescribers Pharmacies Health Professional Licensing Boards Law Enforcement Medical Examiners Medicaid State Agencies Data helps identify: Patients who need care and are not abusing medicine Doctor shoppers Some other forms of drug abuse and diversion Inappropriate prescribing and dispensing
19 What PDMPs provide when prescribers and pharmacies request a patient Rx history 3, 6 or 12 month prescription history, depending on state Prescriber: Name, address, and, some states, phone number Date Rx issued Description of drug: Drug name, quantity, strength, days supply Dispensing pharmacy: Name and address Date dispensed
20 Number of Prescription Drug Monitoring Programs (PDMPs) PDMPs Number of PDMPs Harold Rogers Program Started 10 0 Year
21 Source: PDMP Training & Technical Assistance Center, Brandeis University
22 Source: PDMP Training & Technical Assistance Center, Brandeis University
23 Number of PDMP reports produced by year 4,500,000 4,000,000 3,500,000 3,000,000 2,500,000 Harold Rogers Program Started 2,000,000 1,500,000 1,000, , Est Est. 2008
24 PDMP REPORTS BY TYPE OF USER CA ID KY NV OH OK VA Prescribers & Pharmacists Law Enf. & Regulatory Source: Alliance of States with Prescription Monitoring Programs, 2007
25 PDMPs and Law Enforcement
26 PDMP Data Use in Investigations Typical targets of prescription drug diversion investigations using PDMP data: Suspected doctor shoppers (patients obtaining controlled substances from multiple prescribers and pharmacies), Doctors running pill mills, who knowingly prescribe medically unnecessary drugs for extra income, and Dishonest pharmacists who take advantage of their access to controlled substances.
27 How does law enforcement access PDMP data? Solicited reports L.E. investigators can request PDMP data in every state, but requirements vary Typically, need evidence of an active case; sometimes need court order or subpoena Unsolicited (proactive) reports Model Act recommends that all state PDMPs proactively provide PDMP reports (unsolicited reports) to L.E. 13 states proactively issue unsolicited PDMP reports to L.E. agencies based on analysis of PDMP data
28 Law Enforcement Request Source: Washington State PMP & PDMP Training and Technical Assistance Center
29 Patient Rx History Report Source: Washington State PMP & PDMP Training and Technical Assistance Center
30 Illinois PMP: Statute STATUTE (720 ILCS 570/318) allows the ILPMP to release information to a law enforcement officer, licensing entities or the office of Attorney General that are engaged in an investigation that involves a controlled substance The requestor must have reason to believe that a violation under any state or federal law that involves a controlled substance has occurred The requested information is reasonably related to the investigation of the violation Source: Illinois PMP and PDMP Training & Technical Assistance Center
31 STATISTICS Illinois PMP: Statistics Since 2008 over 2000 requests have been fulfilled for law enforcement purposes o Over 100 distinct requestors o Over 10 states The biggest requestor is the DEA o 38 Requestors o Over 1500 requests o Saves two DEA agents two weeks of traveling to pharmacies and Dr. offices per investigation Avg. 2 reports per month to drug courts Source: Illinois PMP and PDMP Training & Technical Assistance Center
32 How can PDMP data assist investigators in combating diversion? Doctor shopping investigations Reliably identify plausible suspicion of doctor shopping Increase efficiency of investigation by identifying pharmacies and prescribers from which to request records Increase reach of investigation by identifying more remote pharmacies and prescribers used Overall impact of use of PDMP data: enable identification and investigation of more cases, and make more evidence available, increasing likelihood of successful prosecution
33 How can PDMP data assist investigators in combating diversion? Investigations of dishonest prescribers PDMPs can screen data for unusual amounts and types of controlled substances prescribed by a single practitioner E.g., holy trinity of hydrocodone, Xanax, Soma E.g., pill mills Large geographic separation between patients and prescriber E.g., Oxy Express from FL to KY E.g., prescriptions written in GA and filled in AL
34 How can PDMP data assist investigators in combating diversion? Investigations of dishonest pharmacies Unusual patterns of dispensing and of patient location Pharmacy under-reporting of controlled substances dispensed (e.g., to conceal some sales) Can be identified by comparing prescriber and pharmacy records, a process greatly facilitated by electronic prescribing of controlled substances Also by comparing net quantities of controlled substances delivered to a pharmacy and net quantities reportedly dispensed Recently enacted policy in NY
35 Evidence of effectiveness of law enforcement use of PDMP data Perceived effectiveness in preventing/reducing diversion > 90% of law enforcement respondents in KY saw PDMP as effective Time saved in investigations Anecdotal evidence Suggestive findings about drug overdose death rates in selected states that provide unsolicited reports to law enforcement
36 Early PDMPs Impact Example: NY PMP began : NY led the nation in Schedule II stimulants & barbiturate overdoses NY had few opioid overdoses 12% of all Schedule II prescriptions were forged and/or counterfeit Within 5 years: Less than 1% Rx forged or counterfeit Stimulant & Barbiturate sales & overdoses dropped by 95% No reduction in opioid sales Net Schedule II reduction 50%
37 PDMPs and Case Management
38 PDMPs Save Law Enforcement Costs & Monitor Treatment NV Pre-Criminal Intervention Program enrolls & monitors doctor shoppers in rehab saving investigative and prosecution $ See PDMP Center of Excellence Notes from the Field Drug Treatment Programs in ME use PDMP data at patient intake and periodically thereafter to monitor compliance Medical Director Opioid Addiction Treatment Program PDMP data very important See PDMP Center of Excellence Notes from the Field Drug Courts in KY use PDMP data to monitor compliance See PDMP Center of Excellence Notes from the Field
39 States Providing Solicited PDMP Reports to Drug Courts State In state Out of state Authorization Mechanism Alaska Court order or participant release Idaho Under law enforcement and special prosecutors Illinois Under law enforcement and prosecutors Indiana Policy for probation officers and drug court staff Kentucky Direct statutory authority Mississippi Court order Utah Via law enforcement or participant release Wyoming Participant release (probation only) Source: Compiled from information provided by the PDMP Training and Technical Assistance Center, 2012, 2013
40 Prescription Drug Monitoring Program Center of Excellence Notes From the Field NF 2.4 Monitoring and Changing Behavior: The Role of PMP Data in Kentucky Drug Courts August, 2011
41 Kentucky PDMP Kentucky All Schedule Prescription Electronic Reporting (KASPER) is Kentucky s Prescription Drug Monitoring Program (PDMP). KASPER tracks Schedule II V controlled substance prescriptions dispensed within the state as reported by pharmacies and other dispensers. Enhanced KASPER (ekasper) is the real-time web accessed database that provides a tool to help address the misuse, abuse and diversion of controlled pharmaceutical substances. Source: KY Cabinet for Health and Family Services
42 KASPER OPERATION KASPER tracks most Schedule II V substances dispensed in KY. Over 11 million controlled substance prescriptions reported to the system each year. KASPER data is 1 to 3 days old. Dispensers have 1 business day to report. Vendor processes & provides data once per day. Reports available to authorized individuals. Available via web typically within 15 seconds (93% of requests). Available 24/7 from any PC with Web access. Source: KY Cabinet for Health and Family Services
43 Goals of KASPER KASPER was designed as a tool to help address the problem with prescription drug abuse and diversion by providing: A source of information for health care professionals. An investigative tool for law enforcement and regulatory agencies. KASPER was not designed to: Prevent people from getting prescription drugs. Decrease the number of doses dispensed. Source: KY Cabinet for Health and Family Services
44 Access by Law Enforcement Officers KRS 218A.202(6): The Cabinet for Health and Family Services shall be authorized to provide data to: a Kentucky peace officer; a certified or full-time peace officer of another state; a federal peace officer whose duty is to enforce the laws of this Commonwealth, of another state, or of the United States relating to drugs; and who is engaged in a bona fide specific investigation involving a designated person Source: KY Cabinet for Health and Family Services
45 Access by Drug Court Judges KRS 218A.202(6): The Cabinet for Health and Family Services shall be authorized to provide data to: a judge or probation or parole officer administering a diversion or probation program of a criminal defendant arising out of a violation of this chapter or of a criminal defendant who is documented by the court as a substance abuser who is eligible to participate in a court-ordered drug diversion or probation program.
46 Access by Drug Court Judges (cont d) Management of Reports A judge may discuss the information in a KASPER report with the Drug Court participant, but does not provide a copy of the report to anyone including the Drug Court participant. After review the judge may shred the report. Each report has a number that will allow access to the report at any time.
47 Kentucky Drug Courts Use of PDMP Data Used to track a participant s non-medical use or diversion of controlled substances. Rise in prescription drug diversion, abuse and addiction means that an increasing number of drug court participants are enrolled due to involvement with prescription drugs. Information on the prescription histories of participants can play a valuable role in monitoring and changing their behavior. Approximately two thirds of Kentucky drug courts currently make use of PDMP data in a variety of situations.
48 PDMP Data Use by Kentucky Drug Courts Source: Kentucky Administrative Office of the Courts, data collected July 2011
49 Kentucky Drug Courts Use of PDMP Data (cont d) Periodic and random drug tests (drug screens) that analyze hair, blood or urine samples are routinely used to detect illicit and non-medical drug use. However, these tests aren t completely reliable in detecting the presence of all prohibited substances, and are subject to evasion by resourceful and determined drug users. Courts must take other steps to monitor participant behavior to ensure they uphold agreements to remain drug free, or in the case of prescription drugs, use them only as medically indicated.
50 Kentucky Drug Courts Use of PDMP Data (cont d) A typical drug court program in Kentucky consists of 3 phases that gradually give participants more autonomy, plus a post-graduation aftercare phase In one drug court supervised by Vice-Chief Regional Circuit Judge Charles Hickman, PDMP reports are run on participants when they move from one phase of the program to another in order to help confirm that their purchases of controlled substances, if any, are consistent with good clinical care. PDMP data can reveal patterns of prescribing that indicate a participant might be using controlled medications non-medically or diverting them to friends, family or paying customers.
51 Kentucky Drug Courts Use of PDMP Data (cont d) PDMP reports are also run if, at any point in the program, a participant seems to be having unexpected or unexplained setbacks, or if evidence comes to light suggesting illicit drug use (e.g., a positive drug screen) or diversion activity (e.g., unexplained cash in hand). A participant can move on to the next phase only if their behavior as monitored by the court, including the prescription purchases listed in PDMP reports, passes muster.
52 Kentucky Drug Courts Use of PDMP Data (cont d) While a drug screen can t detect drug diversion, only drug use, PDMP data showing medically unnecessary prescriptions are prima facie indicator of possible diversion. PDMP reports are only indicators, not proof, of diversion or misuse. The pharmacies and doctors listed are contacted and records reviewed to confirm that the individual in question actually received the prescriptions dispensed.
53 Purposes of PDMP Data Use by Kentucky Drug Courts Source: Kentucky Administrative Office of the Courts, data collected July 2011
54 Prescription Monitoring Program Model Act of 2010 Section 7, Providing Prescription Monitoring Information (b) The [designated state agency] is authorized to provide information in the prescription monitoring program upon request only to the following persons. (VII) Personnel of the [designated state agency] for purposes of administration and enforcement of this Act, or [insert state controlled substances act], [if any other state statute is applicable, insert or and reference the other statutes]. [Note: A state may determine to authorize additional agencies to request and receive prescription information including substance abuse treatment providers, worker s compensation board reviewers who are health care professionals, drug court judges, department of corrections health care professional staff, and probation departments, if they cannot receive information under other provisions already authorized in (I) through (VII)] Source: Alliance of States with Prescription Monitoring Programs
55 White Paper on PDMP Best Practices Prescription Drug Monitoring Programs: An Assessment of the Evidence for Best Practices September 20, 1012 at Developed with BJA and Pew Charitable Trusts 35 Best and Promising Practices
56 PDMP Best Practice Recommendations Relevant to Drug Courts Enable access to PDMP data by drug courts Provide education to drug court professionals to promote awareness and utilization Link PDMPs with other public health and public safety systems, including drug courts Enact and implement interstate data sharing among PDMPs
57 Potential Mechanisms for Drug Court Use of PDMPs Direct statutory authority Depending upon state laws and regulations: Participant agreement Working through law enforcement Court order or subpoena Working with a participant s health care providers (i.e., prescribers and dispensers) Consult with the state agency administering the PDMP
58 Resources
59 PDMP Center of Excellence Components Web site/clearinghouse Problem Statement user friendly Evaluate PDMP effectiveness, including: Analysis of BJA performance measures Case studies of start-up PDMPs and innovative enhancements Identify best practices Develop innovative uses of PDMP data Support Substance Abuse Prevention Assist Substance Abuse Treatment Assist medical and pharmaceutical education and research Expert panel to guide Center work
60
61 How to find contact information for a state s PDMP? Go to - website of PDMP Training & Technical Assistance Center at Brandeis University Go to the left column of Homepage; under State Contact Information and click on the link for State Contacts That will bring up the name of the primary PDMP contact(s) in each state. Click on a name and the individual s contact information will appear.
62
63 How to find other information about a state s PDMP On the homepage of click the top tab marked Resources On drop down menu, click State Profiles On the next webpage, click the state s name. For each state, there is: The state agency administering the PDMP, Information about the state, Drug schedules monitored, Who may request patient information, Legislation and regulations
64 Prescription Drug Monitoring Program Center of Excellence Brandeis University Supported by the Bureau of Justice Assistance
65 Contact Information PDMP Center of Excellence of Brandeis University John Eadie, MPA, Director Peter Kreiner, Ph.D., Principal Investigator
Protecting Children s Safety: How Prescription Drug Monitoring Programs Can Assist An Update Presenter: John L. Eadie Moderator: Cindy Rodgers
Protecting Children s Safety: How Prescription Drug Monitoring Programs Can Assist An Update Presenter: John L. Eadie Moderator: Cindy Rodgers Audio is streaming through your computer speakers. If you
More informationPrescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort
Prescription Monitoring Program Center for Excellence, Brandeis University April 10-12, 2012 Walt Disney World Swan Resort Accepted Learning Objectives: 1. Explain the current capabilities and contributions
More informationPerspective from Kentucky: Using PMP Data in Drug Diversion Investigations
Prescription Monitoring Program Center of Excellence Notes from the Field NF 2.3 Perspective from Kentucky: Using PMP Data in Drug Diversion Investigations May, 2011 This project was supported by Grant
More informationCommonwealth of Kentucky NASCIO Recognition Awards Nomination Category: Data, Information and Knowledge Management. ekasper
2006 NASCIO Recognition Awards Nomination Category: Data, Information and Knowledge Management ekasper Cabinet for Health and Family Services The Enhanced Kentucky All Schedule Prescription Electronic
More informationThe Prescription Drug Overdose Epidemic
The Prescription Drug Overdose Epidemic Rita Noonan, PhD National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division
More informationApril 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director
More informationPrescription Monitoring Programs: An Update on Interstate Data Sharing
Prescription Monitoring Programs: An Update on Interstate Data Sharing National Conference of State Legislatures July 28, 2010 David R. Hopkins Kentucky Cabinet for Health and Family Services Office of
More informationAddressing Prescription Drug Abuse. Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust
Addressing Prescription Drug Abuse Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust Outline 1. Prescription Drug Monitoring Programs 2. Federal policy landscape including
More informationMedicare Advantage Outreach and Education Bulletin
Medicare Advantage Outreach and Education Bulletin Blue Cross and Blue Shield of Georgia Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain
More informationAn Update on Kentucky All Schedule Prescription Electronic Reporting (KASPER)
An Update on Kentucky All Schedule Prescription Electronic Reporting (KASPER) Mary Reinle Begley Inspector General Kentucky David R. Hopkins KASPER Program Manager Office of Inspector General Health Care
More informationUsing PDMP Data to Guide Interventions with Possible At-Risk Prescribers
Prescription Drug Monitoring Program Center of Excellence at Brandeis Using PDMP Data to Guide Interventions with Possible At-Risk Prescribers October 2014 This project was supported by Grant No. 2011-PM-BX-K002
More informationNorth Carolina, like the rest of the nation, has been experiencing
INVITED COMMENTARY The North Carolina Controlled Substances Reporting System: A Valuable Tool for Combating Prescription Drug Misuse William D. Bronson Prescription drug misuse is a growing problem that
More informationPrescription Monitoring Program Center of Excellence at Brandeis. Drug-Related Deaths in Virginia: Medical Examiner Use of PMP Data
Prescription Monitoring Program Center of Excellence at Brandeis Notes from the Field NF 2.6 Drug-Related Deaths in Virginia: Medical Examiner Use of PMP Data December, 2011 This project was supported
More information4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update
Bureau of Professional Licensing MAPS Updates & Opportunities April 28, 2018 Presented by Andrew Hudson, Manager Haley Winans, Analyst Drug Monitoring Section Bureau of Professional Licensing BPL-MAPS@Michigan.gov
More informationMedicare Advantage Outreach and Education Bulletin
Medicare Advantage Outreach and Education Bulletin Anthem Blue Cross and Blue Shield Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain management.
More informationUsing Prescription Drug Monitoring Program Data to Advance Prevention Planning
September 13, 2016 Using Prescription Drug Monitoring Program Data to Advance Prevention Planning Emerging Drug Issues and Trends Chelsey Goddard, Director, SAMHSA s Center for the Application of Prevention
More informationC U S T O M E R D R I V E N. B U S I N E S S M I N D E D.
MAPS Update May 4, 2018 Presented by Kim Gaedeke, Acting Deputy Director Department of Licensing and Regulatory Affairs Andrew Hudson, Manager Drug Monitoring Section BPL-MAPS@Michigan.gov 517-373-1737
More informationPrescription Drug Abuse National Perspective
Prescription Drug Abuse National Perspective Timothy P. Condon, Ph.D. Science Policy Advisor Office of the Director White House Office of National Drug Control Policy Commonly Abused Prescription Drugs
More information5/16/2016. Roadmap. Legal Competencies. Prescription Drug Overdose at Epidemic Levels
Legal & Policy Approaches to Reducing Prescription Drug Overdose Disclaimer Funding for this activity was made possible (in part) by the Centers for Disease Control and Prevention. The views expressed
More informationInterstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science
Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science National Center for Injury Prevention and Control Division of Analysis,
More informationCDC s Approach to Addressing the Opioid Overdose Epidemic
CDC s Approach to Addressing the Opioid Overdose Epidemic Sarah Bacon National Center for Injury Prevention and Control Division of Unintentional Injury Prevention June 23, 2016 500,000 drug overdose deaths
More informationWisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015
Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015 1 Presenter Andrea Magermans Program Analyst of the Wisconsin PDMP Wisconsin Department of Safety and Professional
More informationHigh-Decile Prescribers: All Gain, No Pain?
High-Decile Prescribers: All Gain, No Pain? Len Paulozzi, MD, MPH National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center for Injury Prevention and
More informationState of California Department of Justice. Bureau of Narcotic Enforcement
State of California Department of Justice Bureau of Narcotic Enforcement Prescription Drugs in the U.S. At least half of all Americans take one prescription drug regularly, with one in six taking three
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
More informationPDMP prescriber use mandates: characteristics, current status, and outcomes in selected states
Prescription Drug Monitoring Program Center of Excellence at Brandeis COE Briefing PDMP prescriber use mandates: characteristics, current status, and outcomes in selected states Revision 3, May 2016* *The
More informationAHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion
Fraud and Compliance Forum, October 2017. Click here to access audio. AHLA X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion Michelle Bergholz Frazier Senior Vice President,
More informationPrescription Behavior Surveillance System Len Paulozzi, MD, MPH
Prescription Behavior Surveillance System Len Paulozzi, MD, MPH Centers for Disease Control and Prevention Centers for Disease Control and Prevention National Center for Injury Prevention and Control Harold
More informationProject Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data
Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data Presented to Bureau of Justice Assistance Harold Rogers Prescription
More informationData Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky
Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky Svetla Slavova, PhD Terry Bunn, PhD Bureau of Justice Assistance Research-Practitioner Partnership & Data-Driven Pilots
More informationOpioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016
1 Opioid Abuse in Iowa Rx to Heroin Iowa Governor s Office of Drug Control Policy January 2016 Why Is This Important? 2 3 National Rx Painkiller Trends CDC, 2013 4 National Rx-Heroin Trends NIH, 2015 5
More informationUTAH S CONTROLLED SUBSTANCE DATABASE PROGRAM (CSDB)
UTAH S CONTROLLED SUBSTANCE DATABASE PROGRAM (CSDB) Harold Rogers Prescription Drug Monitoring Program National Meeting Washington, D.C. August 17 August 19 th, 2016 Marvin H. Sims, C.S. DataBase Administrator
More informationTechnical Assistance Guide No Recommended PDMP Reports to Support Licensing/Regulatory Boards and Law Enforcement Investigations
Technical Assistance Guide No. 02-14 Recommended PDMP Reports to Support Licensing/Regulatory Boards and Law Enforcement Investigations This project was supported by Grant No. 2011-PM-BX-K001 awarded by
More informationThe Wisconsin Prescription Drug Monitoring Program
The Wisconsin Prescription Drug Monitoring Program DHS 2018 WI Opioid Forum April 12, 2018 Learning Objectives 1. How the WI epdmp supports healthcare professionals in making informed prescribing, dispensing
More informationChallenges for U.S. Attorneys Offices (USAO) in Opioid Cases
Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Overview On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being
More informationReport to the Legislature: Recommendations on Required Use and Other Uses of the MN Prescription Monitoring Program Database
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp Minnesota Board of
More informationKentucky All Schedule Prescription Electronic Reporting (KASPER)
Kentucky All Schedule Prescription Electronic Reporting (KASPER) Phyllis Millspaugh Manager, Behavioral Health Prevention and Promotion Kentucky Cabinet for Health and Family Services Using PDMP Data to
More informationMANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling
MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN State Senator Alberta Darling A NATIONAL PROBLEM According to the 2014 National Survey on Drug Use and Health: 435,000 Americans have used heroin
More information4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP
New Mexico s Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy New Mexico and the PMP In 2012, New Mexico had the 3 nd Highest Overdose Death Rate in Nation.! 492 Deaths or a rate of 23.6
More informationPrescription Opioid Overdose in Oregon: A public health perspective
Prescription Opioid Overdose in Oregon: A public health perspective Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Health Authority All-Cause Mortality,
More informationOpioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative
Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative John W. McIlveen, Ph.D., LMHC, State Opioid Treatment Authority, Oregon Health Authority, Addictions and Mental Health Division
More informationArkansas Department of Health
Arkansas Department of Health 4815 West Markham Street Little Rock, Arkansas 72205-3867 Telephone (501) 661-2000 Governor Mike Beebe Nathaniel Smith, MD, MPH, Interim Director and State Health Officer
More informationThe Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.
The Wisconsin Prescription Drug Monitoring Program Wisconsin Nurses Association Jail Health Care Conference May 21, 2018 WI PDMP Timeline PDMP Overview January 2013 WI PDMP operational April 2017 WI epdmp
More informationMichael M. Miller, MD, FASAM, FAPA
Michael M. Miller, MD, FASAM, FAPA mmiller@rogershospital.org Medical Director, Herrington Recovery Center (HRC) Rogers Memorial Hospital Oconomowoc, Wisconsin Vice Speaker Wisconsin Medical Society Clinical
More informationRole of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx
Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services
More informationNC General Statutes - Chapter 90 Article 5E 1
Article 5E. North Carolina Controlled Substances Reporting System Act. 90-113.70. Short title. This Article shall be known and may be cited as the "North Carolina Controlled Substances Reporting System
More informationEast Regional PMP. PMP Center of Excellence Update. Baltimore, MD April 6, 2011
East Regional PMP Meeting: PMP Center of Excellence Update Baltimore, MD April 6, 2011 US Surgeon General s Expert Panel on Prescription Drug Abuse in Youth: March 29. 2011 Sources of Prescription Drugs
More informationProvider Education & Utilization Initiatives Alliance of States with PMPs East Regional Meeting
Provider Education & Utilization Initiatives Alliance of States with PMPs East Regional Meeting Baltimore, MD April 5, 2011 Massachusetts Department of Public Health MA Prescription Monitoring Program
More informationSAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM
Sorin Buga, MD Associate Clinical Professor Department of Supportive Care City of Hope National Medical Center SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM Click to edit Master Presentation Date Disclosure
More informationPrescription Drug Monitoring Program Update. Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017
Prescription Drug Monitoring Program Update Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017 Objectives Brief historical overview of opioids Review of PDMP information Discuss ideas from
More informationOpioid Use and Other Trends
Opioid Use and Other Trends National Overview Across the nation communities are struggling with a devastating increase in the number of people misusing opioid drugs, leading many to identify the current
More informationPrescription Drug Abuse Task Force Rx Report Card
San Diego County Prescription Drug Abuse Task Force 2016 Rx Report Card October 2016 Key Measures of Prescription Drug and Heroin Problems in San Diego County. Visit www.sandiegorxabusetaskforce.org for
More informationArkansas Prescription Monitoring Program
Arkansas Prescription Monitoring Program FY 2017 Second Quarter Report October December 2016 Arkansas Prescription Monitoring Program Quarterly Report October December, Fiscal year 2017 Act 304 of 2011
More informationOpioids drive continued increase in drug overdose deaths
CDC: Drug overdose deaths increase for 11th consecutive year Opioids drive continued increase in drug overdose deaths Atlanta, GA, USA (February 20, 2013) - Drug overdose deaths increased for the 11th
More informationPDMP Tools to Identify Red Flag Situations
PDMP Tools to Identify Red Flag Situations Prescription Drug Monitoring Programs CBI Baltimore, MD February 7, 2017 Grant Carrow, Ph.D. Project Consultant The Heller School for Social Policy and Management
More informationState, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP
State, District, or Territory Alabama Arizona Arkansas Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate, the applicant shall have a current
More informationPRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE September 20, 2013 Association of State and Territorial Health Officials Annual Meeting R. Gil Kerlikowske Director of National Drug Control Policy National
More information2018 Annual Meeting & Educational Conference Opioids In Workers Compensation: Research From WCRI
2018 Annual Meeting & Educational Conference Opioids In Workers Compensation: Research From WCRI John W. Ruser, Ph.D. NCSI 2018 Annual Meeting June 12, 2018 AGENDA Introduce WCRI Opioid dispensing to injured
More informationShawn A. Ryan, MD, MBA Assistant Professor, Dept. of Emergency Medicine, University of Cincinnati Chair of Quality & Patient Safety, Jewish
Shawn A. Ryan, MD, MBA Assistant Professor, Dept. of Emergency Medicine, University of Cincinnati Chair of Quality & Patient Safety, Jewish Hospital-Mercy Health Partners Addiction Specialist, BrightView
More informationStates with Authority to Require Nonresident Pharmacies to Report to PMP
States with Authority to Require Nonresident Pharmacies to Report to PMP Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug
More informationPennsylvania Prescription Drug Monitoring Program Trends,
DEA Intelligence Report Brief DEA-PHL-DIR-006-17 Pennsylvania Prescription Drug Monitoring Program Trends, 2014-2015 December 2016 1 Executive Summary The abuse and diversion of pharmaceutical drugs, particularly
More informationSTATE PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS): A NATIONAL PERSPECTIVE
STATE PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS): A NATIONAL PERSPECTIVE PRESENTATION ON BEHALF OF THE NATIONAL ASSOCIATION OF STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) BY SHERRY L. GREEN OVERVIEW
More information11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?
Where Can I Find A Copy of the PDMP Law? Alabama Uniform Controlled Substances Act Code of Alabama 1975 20-2- (Article 10) -210 through 220 and Rules 420-7-2-.11 through.13 1 Why Was the Law Established?
More informationThe Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country
Integrating Primary and Behavioral Health Care Through the Lens of Prevention July 14, 2016 New Orleans, Louisiana The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin
More informationLegal and Policy Approaches to Reducing Prescription Drug Overdose
Legal and Policy Approaches to Reducing Prescription Drug Overdose Presenters: Corey Davis and Kristi Weeks Facilitators: Cindy Rodgers and Erica Streit-Kaplan On your telephone please dial: 1-866-835-7973
More informationWashington State PMP Data Mapping Project
Washington State PMP Data Mapping Project 2014 Category 3 Grant Harold Rogers Category 3 Grantee Meeting February 25, 2015 Washington State BACKGROUND: OPIOID ISSUES AND PLANNING 2 WA Unintentional Opioid
More informationModel State Electronic Prescription Monitoring Program Legislation
Model State Electronic Prescription Monitoring Program Legislation Produced by the University of Wisconsin s Pain & Policy Studies Group (PPSG) in partnership with the American Cancer Society Cancer Action
More information4/10/2016. Legal & Policy Approaches to Reducing Opioid Poisonings. Overview. Background. Health Directors Legal Conference April 19, 2016
Legal & Policy Approaches to Reducing Opioid Poisonings Health Directors Legal Conference April 19, 2016 Corey Davis Network for Public Health Law Overview Fatal opioid overdose is at epidemic levels Many
More informationControlled Substance Prescribing and Diversion. Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control
Controlled Substance Prescribing and Diversion Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control In 2010, approximately 38,329 unintentional drug overdose deaths occurred in the United States,
More informationUniversity of Pittsburgh
Learning Objectives Participants will be able to: Associate the history of prescription drug use in America with the current trend of prescription drug abuse; Differentiate between the three most commonly
More informationA Bill Regular Session, 2015 SENATE BILL 717
Stricken language would be deleted from and underlined language would be added to present law. 0 State of Arkansas 0th General Assembly As Engrossed: S// H// A Bill Regular Session, SENATE BILL By: Senator
More informationPerformance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)
Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and
More informationArkansas Prescription Monitoring Program
Arkansas Prescription Monitoring Program FY 2016 Third Quarter Report January-March 2016 Arkansas Prescription Monitoring Program Quarterly Report January March, Fiscal year 2016 Act 304 of 2011 authorized
More informationWA PMP Access by Public Payers. PDMP North Regional Meeting St. Louis, MO April 23-24
WA PMP Access by Public Payers PDMP North Regional Meeting St. Louis, MO April 23-24 Public Insurer Access PDMP Statute: Allows PDMP data to be provided to Medicaid and Workers Compensation Primary Goal:
More informationPrescription Drug Monitoring Program Glossary of Terms and Organizations
Prescription Drug Monitoring Program Glossary of Terms and Organizations This document is a compilation of terms and acronyms used by and for Prescription Drug Monitoring Programs. Additional information
More informationLegal & Policy Approaches to Reducing Prescription Drug Overdose
Legal & Policy Approaches to Reducing Prescription Drug Overdose August 28, 2014 Public Health Law Series Webinar: How to Use Webex Audio: If you can hear us through your computer, you do not need to use
More informationPRESCRIBING GUIDELINES
Ohio Department of Health RESPONSE TO OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC: PRESCRIBING GUIDELINES MIPA CONFERENCE PREVENTING INJURY: FROM RESEARCH TO PRACTICE TO PEOPLE SEPTEMBER 30, 2013 Christy
More informationPrescription Drug Monitoring Programs and Other State-Level Strategies
Prescription Drug Monitoring Programs and Other State-Level Strategies Interventions to Reduce Opioid-Related Harms: Misuse, Abuse, Addiction, and Overdose Tamara M. Haegerich, PhD Acting Associate Director
More informationReport to the Legislature: Unsolicited Reporting Criteria Established and Process Review MN Prescription Monitoring Program
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp Minnesota Board of
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Alaska Requires adoption of regulations that provide that a practitioner query the PDMP prior to dispensing, prescribing, or administering a Sch. II or III controlled substance; query is not required for
More informationChairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield and
United States House of Representatives Committee on Energy and Commerce Subcommittee on Commerce, Manufacturing and Trade Hearing on Chairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield
More informationBlue Cross of Idaho Addresses State s Opioid Issue
Blue Cross of Idaho Addresses State s Opioid Issue BY THE NUMBERS - Opioid Management page 3 THE PROBLEM - How Preventing Pain Hurt Us page 4 THE SOLUTIONS - Idaho State Board Of Pharmacy Prescription
More informationPrescription Monitoring Program (PMP)
06/15/2018 FACT SHEET Implementation of Enacted Prescribing Limits and Requirements and Relevant Opioid Prescribing Laws and Rules Background: The 2016 law (Chapter 488) makes five major changes to opioid
More informationChanges to the Eighth Edition
Pharmacy Practice and the Law, Eighth Edition Includes Navigate 2 Advantage Access By Richard R. Abood, BS Pharm, JD-Professor Emeritus Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences,
More informationControlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System
Controlled Substance Prescribing: A Physician s Guide Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System Objectives Review schedules of controlled substances and their propensity for
More informationOpioid Abuse and Prescribing. Dr. Mitchell Mutter Director of Special Projects
Opioid Abuse and Prescribing Dr. Mitchell Mutter Director of Special Projects Auburn University February 22, 2019 Disclosure Statement of Financial Interest I, Mitchell Mutter, DO NOT have a financial
More informationCurbing Prescription Drug Abuse in Medicaid
Curbing Prescription Drug Abuse in Medicaid Joint Legislative Health Care Oversight Committee October 12, 2010 Dr. Lisa Weeks, BSPharm, PharmD Pharmacy and Ancillary Services Division of Medical Assistance
More informationCombating the Opiate Crisis in Ohio
Combating the Opiate Crisis in Ohio In 2011, Gov. John R. Kasich announced the establishment of the Governor s Cabinet Opiate Action Team to fight opiate abuse in Ohio. Ohio is combating drug abuse through
More informationPDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health
PDMP Track: Linking and Mapping PDMP Data Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health Disclosure Statement Gillian Leichtling and Chris Baumgartner have disclosed no
More informationSTATES RESPONSES TO MAIL ORDER PHARMACIES DELIVERING OR DISPENSING PRESCRIPTION DRUGS INTO THEIR STATES
STATES RESPONSES TO MAIL ORDER PHARMACIES DELIVERING OR DISPENSING PRESCRIPTION DRUGS INTO THEIR STATES Review of Information Collected January 4, 2005 Method of Information Collection Staff of the National
More informationPDSA Delaware: A Data and Logic Model Driven Prescription Drug and Substance Abuse Change Approach for Delaware
PDSA Delaware: A Data and Logic Model Driven Prescription Drug and Substance Abuse Change Approach for Delaware Funded by BJA Harold Rogers Program FY2014 Award #2014-PM-BX-0002 February 25 th, 2015 Data-Driven
More informationStrategies to Manage The Opioid Crisis
Strategies to Manage The Opioid Crisis Matt Feehery, LCDC Senior Vice President & CEO PaRC (Prevention & Recovery Center) Behavioral Health Services February 1, 2018 A Pill for Your Pain But my doctor
More informationControlled Substances Program. For Academic Units
Brigham Young University Page 1 Provo, Utah Controlled Substances Program For Academic Units Last Revised: November 30, 2009 Brigham Young University Page 2 TABLE OF CONTENTS Section Title Page 1.0 Overview
More informationWHAT YOU NEED TO KNOW TO ABOUT AB 474
WHAT YOU NEED TO KNOW TO ABOUT AB 474 PRESENTED BY: NEVADA STATE BOARD OF OSTEOPATHIC MEDICINE 2275 Corporate Circle, Suite 210 Henderson, NV 89074 702-732-2147 Fax 702-732-2079 Web Site: www.bom.nv.gov
More informationIllinois Prescription Monitoring Program. Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program
Illinois Prescription Monitoring Program Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program Agenda Provide an overview of the Illinois Prescription Monitoring Program
More informationGreenbrier County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
More informationPrescription Drug Monitoring Programs
Kristin Finklea Specialist in Domestic Security Lisa N. Sacco Analyst in Illicit Drugs and Crime Policy Erin Bagalman Analyst in Health Policy March 24, 2014 Congressional Research Service 7-5700 www.crs.gov
More informationPrescription Drug Monitoring Program (PDMP) Delaware. Information contained in this presentation is accurate as of November 2017
Prescription Drug Monitoring Program (PDMP) Delaware Information contained in this presentation is accurate as of November 2017 Dr. Michael C. Dejos, PharmD, BCPS, LSSBB 2 Acknowledgements Christian Ruffin,
More informationASPMN Conference Baltimore, Maryland
ASPMN Conference Baltimore, Maryland Prescribing Controlled Substances Managing Risk and Optimizing Outcomes September 13, 2012 Tracey Fremd, NP Tracey Fremd Consulting, Inc. Most Common Uses for Controlled
More information